| Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial J McAuley, KM Boyer, D Patel, M Mets, C Swisher, N Roizen, C Wolters, ... Clinical infectious diseases 18 (1), 38-72, 1994 | 481 | 1994 |
| Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening KM Boyer, E Holfels, N Roizen, C Swisher, D Mack, J Remington, ... American journal of obstetrics and gynecology 192 (2), 564-571, 2005 | 335 | 2005 |
| Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction M D’Souza, AP Fontenot, DG Mack, C Lozupone, S Dillon, A Meditz, ... The Journal of Immunology 179 (3), 1979-1987, 2007 | 319 | 2007 |
| Eye manifestations of congenital toxoplasmosis MB Mets, E Holfels, KM Boyer, CN Swisher, N Roizen, L Stein, M Stein, ... American journal of ophthalmology 123 (1), 1-16, 1997 | 314 | 1997 |
| Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I R McLeod, SP Muench, JB Rafferty, DE Kyle, EJ Mui, MJ Kirisits, DG Mack, ... International journal for parasitology 31 (2), 109-113, 2001 | 254 | 2001 |
| Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection. JR Mineo, R McLeod, D Mack, J Smith, IA Khan, KH Ely, LH Kasper Journal of immunology (Baltimore, Md.: 1950) 150 (9), 3951-3964, 1993 | 229 | 1993 |
| Neurologic and developmental outcome in treated congenital toxoplasmosis N Roizen, CN Swisher, MA Stein, J Hopkins, KM Boyer, E Holfels, ... Pediatrics 95 (1), 11-20, 1995 | 200 | 1995 |
| Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception N Vogel, M Kirisits, E Michael, H Bach, M Hostetter, K Boyer, R Simpson, ... Clinical infectious diseases 23 (5), 1055-1060, 1996 | 175 | 1996 |
| Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of A x B/B x A recombinant inbred and B10 congenic mice. R McLeod, E Skamene, CR Brown, PB Eisenhauer, DG Mack Journal of immunology (Baltimore, Md.: 1950) 143 (9), 3031-3034, 1989 | 144 | 1989 |
| Crystal structure of HLA-DP2 and implications for chronic beryllium disease S Dai, GA Murphy, F Crawford, DG Mack, MT Falta, P Marrack, ... Proceedings of the National Academy of Sciences 107 (16), 7425-7430, 2010 | 136 | 2010 |
| HLA-class II genes modify outcome of Toxoplasma gondii infection DG Mack, JJ Johnson, F Roberts, CW Roberts, RG Estes, C David, ... International journal for parasitology 29 (9), 1351-1358, 1999 | 132 | 1999 |
| Immune responses associated with early survival after peroral infection with Toxoplasma gondii. R McLEOD, P Eisenhauer, D Mack, C Brown, G Filice, G Spitalny Journal of immunology (Baltimore, Md.: 1950) 142 (9), 3247-3255, 1989 | 130 | 1989 |
| New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine … DG Mack, R McLeod Antimicrobial agents and chemotherapy 26 (1), 26-30, 1984 | 128 | 1984 |
| Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital toxoplasma challenge. R McLeod, JK Frenkel, RG Estes, DG Mack, PB Eisenhauer, G Gibori Journal of immunology (Baltimore, Md.: 1950) 140 (5), 1632-1637, 1988 | 111 | 1988 |
| Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis. DV Patel, EM Holfels, NP Vogel, KM Boyer, MB Mets, CN Swisher, ... Radiology 199 (2), 433-440, 1996 | 110 | 1996 |
| Immune Response of Mice to Ingested Toxoplasma gondii: A Model of Toxoplasma Infection Acquired by Ingestion R McLeod, RG Estes, DG Mack, H Cohen Journal of infectious diseases 149 (2), 234-244, 1984 | 94 | 1984 |
| Delivery of antimicrobials into parasites BU Samuel, B Hearn, D Mack, P Wender, J Rothbard, MJ Kirisits, E Mui, ... Proceedings of the National Academy of Sciences 100 (24), 14281-14286, 2003 | 93 | 2003 |
| Toxoplasma gondii—new advances in cellular and molecular biology R McLeod, D Mack, C Brown Experimental parasitology 72 (1), 109-121, 1991 | 90 | 1991 |
| Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group R McLeod, D Mack, R Foss, K Boyer, S Withers, S Levin, J Hubbell Antimicrobial agents and chemotherapy 36 (5), 1040-1048, 1992 | 79 | 1992 |
| Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease MT Falta, C Pinilla, DG Mack, AN Tinega, F Crawford, M Giulianotti, ... The Journal of experimental medicine 210 (7), 1403, 2013 | 78 | 2013 |
